In a recent report, HER263-71-specific CD8+ CTLs are responsible for tumor regression in the 4T1.2/HER2 and CT26/HER2 models7 and in a mouse mammary tumor (D2F2/E2 expressing HER2) model8. The gene discussed is ERBB2; the disease is breast cancer.